{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T14:25:12Z","timestamp":1781360712653,"version":"3.54.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Vasoplegia is defined by systemic vascular resistance (SVR) &lt; 800 dynes\u00b7s\/cm<jats:sup>5<\/jats:sup>, cardiac index (CI) &gt; 2.2\u2009L\/min\/m<jats:sup>2<\/jats:sup>, and hypotension, and is associated with poor outcomes. Maintaining adequate blood pressure with vasopressors is considered essential in these cases. However, some patients exhibit low SVR and high CI while maintaining normal blood pressure, and the benefits of vasopressor use in this population have not been studied.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This study utilized the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database and included intensive care unit (ICU) patients who met the criteria for vasoplegic status, defined as SVR\u2009&lt;\u2009800 dynes\u00b7s\/cm<jats:sup>5<\/jats:sup>, CI\u2009&gt;\u20092.2\u2009L\/min\/m<jats:sup>2<\/jats:sup>, and mean arterial pressure (MAP) \u2265 60 mmHg. The primary outcome was kidney deterioration, and the secondary outcome was prolonged ICU stay (defined as &gt; 3 days). Firth\u2019s logistic regression was used to analyze associations. Subgroup analyses and interaction term p-values were also assessed to evaluate the modifying effects of relevant variables on the relationship between vasopressor use and the outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Among 319 patients, 6.0% experienced kidney deterioration, and 24.1% had a prolonged ICU stay. Vasopressor use was not significantly associated with kidney deterioration (odds ratio [OR]: 2.96 [0.33\u201329.81], p\u2009=\u20090.321); however, it was significantly associated with prolonged ICU stay (OR: 4.71 [2.15\u201310.77], p\u2009&lt;\u20090.001). Sensitivity analyses confirmed these findings across vasopressor types. Subgroup analysis showed that vasopressor use was associated with a higher risk of prolonged ICU stay in patients without congestive heart failure, without heart surgery, and without chronic kidney disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In patients with low SVR and normal blood pressure, vasopressor use was associated with longer ICU stays but not kidney protection.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0333365","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:22:31Z","timestamp":1759512151000},"page":"e0333365","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low systemic vascular resistance with normal blood pressure: Do we need vasopressors?"],"prefix":"10.1371","volume":"20","author":[{"given":"Min Woo","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6844-0614","authenticated-orcid":true,"given":"Shin Young","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2528-173X","authenticated-orcid":true,"given":"Yoonjin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"1","key":"pone.0333365.ref001","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13054-018-2102-1","article-title":"Definitions and pathophysiology of vasoplegic shock","volume":"22","author":"S Lambden","year":"2018","journal-title":"Crit Care"},{"issue":"4","key":"pone.0333365.ref002","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14797\/mdcvj.1245","article-title":"Vasoplegia: A Review","volume":"19","author":"I Ratnani","year":"2023","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"4","key":"pone.0333365.ref003","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1177\/0300060517743836","article-title":"Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms","volume":"46","author":"A-M Burgdorff","year":"2018","journal-title":"J Int Med Res"},{"issue":"17","key":"pone.0333365.ref004","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.108.814533","article-title":"Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome","volume":"120","author":"MA Levin","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"pone.0333365.ref005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0003-4975(96)01061-2","article-title":"Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response","volume":"63","author":"EM Boyle","year":"1997","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"pone.0333365.ref006","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0003-4975(99)00729-8","article-title":"Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass","volume":"68","author":"M Str\u00fcber","year":"1999","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"pone.0333365.ref007","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0022-5223(96)70458-0","article-title":"Human cytokine responses to cardiac transplantation and coronary artery bypass grafting","volume":"111","author":"S Wan","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"pone.0333365.ref008","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1540-8191.2000.tb00470.x","article-title":"Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance","volume":"15","author":"T Carrel","year":"2000","journal-title":"J Card Surg"},{"issue":"3","key":"pone.0333365.ref009","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.athoracsur.2011.04.020","article-title":"Transfusion increases the risk for vasoplegia after cardiac operations","volume":"92","author":"A Alfirevic","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"pone.0333365.ref010","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0003-4975(01)02486-9","article-title":"Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function","volume":"71","author":"A Mekontso-Dessap","year":"2001","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"pone.0333365.ref011","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.healun.2011.10.010","article-title":"Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era","volume":"31","author":"M Patarroyo","year":"2012","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"pone.0333365.ref012","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options","volume":"24","author":"LW Busse","year":"2020","journal-title":"Crit Care"},{"issue":"1","key":"pone.0333365.ref013","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial","volume":"126","author":"LA Hajjar","year":"2017","journal-title":"Anesthesiology"},{"issue":"11","key":"pone.0333365.ref014","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00134-019-05801-z","article-title":"Vasopressor therapy in critically ill patients with shock","volume":"45","author":"JA Russell","year":"2019","journal-title":"Intensive Care Med"},{"issue":"1","key":"pone.0333365.ref015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13054-021-03605-6","article-title":"Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: do not confound access route and specific drug complications!","volume":"25","author":"R Jouffroy","year":"2021","journal-title":"Crit Care"},{"issue":"10","key":"pone.0333365.ref016","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.107.728840","article-title":"Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease","volume":"118","author":"CB Overgaard","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"pone.0333365.ref017","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1053\/j.jvca.2018.11.025","article-title":"A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy","volume":"33","author":"JP Ortoleva","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"pone.0333365.ref018","doi-asserted-by":"crossref","first-page":"962670","DOI":"10.3389\/fphys.2022.962670","article-title":"Optimal target blood pressure in critically ill adult patients with vasodilatory shock: A systematic review and meta-analysis","volume":"13","author":"H Yoshimoto","year":"2022","journal-title":"Front Physiol"},{"issue":"1","key":"pone.0333365.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"AEW Johnson","year":"2023","journal-title":"Sci Data"},{"issue":"1","key":"pone.0333365.ref020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.athoracsur.2012.02.010","article-title":"Prolonged stay in intensive care unit is a powerful predictor of adverse outcomes after cardiac operations","volume":"94","author":"B Mahesh","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"14","key":"pone.0333365.ref021","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/sim.7273","article-title":"Firth\u2019s logistic regression with rare events: accurate effect estimates and predictions?","volume":"36","author":"R Puhr","year":"2017","journal-title":"Stat Med"},{"issue":"8","key":"pone.0333365.ref022","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1159\/000539808","article-title":"Tachycardia and Acute Kidney Injury among Critically Ill Patients with Sepsis: A Prospective Observational Study","volume":"53","author":"N Hayase","year":"2024","journal-title":"Blood Purif"},{"issue":"4","key":"pone.0333365.ref023","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3349\/ymj.2013.54.4.965","article-title":"Acute kidney injury in patients with sepsis and septic shock: risk factors and clinical outcomes","volume":"54","author":"SH Suh","year":"2013","journal-title":"Yonsei Med J"},{"issue":"1","key":"pone.0333365.ref024","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MAJ.0000000000000341","article-title":"Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment","volume":"349","author":"S Omar","year":"2015","journal-title":"Am J Med Sci"},{"issue":"1","key":"pone.0333365.ref025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13054-018-1967-3","article-title":"Vasoplegia treatments: the past, the present, and the future","volume":"22","author":"B Levy","year":"2018","journal-title":"Crit Care"},{"issue":"18","key":"pone.0333365.ref026","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis","volume":"319","author":"WF McIntyre","year":"2018","journal-title":"JAMA"},{"issue":"11","key":"pone.0333365.ref027","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"L Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"4","key":"pone.0333365.ref028","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/SHK.0000000000000879","article-title":"Non-Hemodynamic Effects of Catecholamines","volume":"48","author":"C Hartmann","year":"2017","journal-title":"Shock"},{"issue":"5","key":"pone.0333365.ref029","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/ALN.0b013e31824f9669","article-title":"Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction","volume":"116","author":"N Ducrocq","year":"2012","journal-title":"Anesthesiology"},{"key":"pone.0333365.ref030","first-page":"216","article-title":"Resistance reconstructed estimation of total peripheral resistance from computationally derived cardiac output - biomed 2013","volume":"49","author":"LK Hill","year":"2013","journal-title":"Biomed Sci Instrum"},{"issue":"17","key":"pone.0333365.ref031","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"P Asfar","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0333365.ref032","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","article-title":"Adrenergic nervous system in heart failure: pathophysiology and therapy","volume":"113","author":"A Lymperopoulos","year":"2013","journal-title":"Circ Res"},{"issue":"10","key":"pone.0333365.ref033","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.3390\/jcm13103017","article-title":"The Surgical Stress Response and Anesthesia: A Narrative Review","volume":"13","author":"R Ivascu","year":"2024","journal-title":"J Clin Med"},{"issue":"3","key":"pone.0333365.ref034","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.00090.2019","article-title":"Vascular \u03b11-adrenergic sensitivity is enhanced in chronic kidney disease","volume":"317","author":"JD Sprick","year":"2019","journal-title":"Am J Physiol Regul Integr Comp Physiol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:22:38Z","timestamp":1759512158000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333365"}},"subtitle":[],"editor":[{"given":"Kiyan","family":"Heybati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0333365","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]}}}